Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
Molgramostim + sucralfate + hyaloronan by Reponex Pharmaceuticals for Venous Leg Ulcers (Crural Ulcer): Likelihood of Approval
Molgramostim + sucralfate + hyaloronan is under clinical development by Reponex Pharmaceuticals and currently in Phase II for Venous Leg...